Table 1 Baseline characteristics of patients cohort
Parameters | SR (n = 9) | AF (n = 9) | Patients (n = 18) | P-value |
|---|---|---|---|---|
Age | 62 ± 3.3 | 67 ± 3.0 | 64.1 (44–84) | 0.229 |
Female gender | 22 | 22 | 22% | 1.000 |
Diabetes | 11 | 11 | 11% | 1.000 |
EF | 59 ± 4.9 | 44 ± 7.2 | 51.3 (16–78) | 0.114 |
EF > 50% | 8 | 5 | 44% | 0.200 |
BMI | 27.6 ± 1.9 | 31.7 ± 3.2 | 29.6 (20–53.7) | 0.292 |
NYHA III | 1 | 5 | 66% | 0.049* |
Urgency | ||||
In-hospital | 4 | 5 | 50% | 0.637 |
Elective | 5 | 4 | 50% | |
Procedure type | ||||
CABG | 4 | 4 | 8/18 | 0.940 |
CABG + valve | 1 | 1 | 2/18 | |
Aortic valve | 3 | 1 | 4/18 | |
Aortic + mitral valve | 1 | 1 | 2/18 | |
LVAD | 1 | 1 | 2/18 | |
Clinical frailty | ||||
CFS class 4/5 | 3 | 6 | 50% | 0.157 |
Echocardiogram | ||||
LV diast diameter | 5.1 ± 0.6 | 5.7 ± 1.1 | 5.5 (4.0–7.3) | 0.422 |
LV syst diameter | 3.5 ± 0.9 | 4.3 ± 1.9 | 4.0 (2.4–6.9) | 0.623 |
LA diameter | 4.2 ± 0.8 | 11.1 ± 16.7 | 4.5 (2.8–4.9) | 0.295 |
E/A ratio | 1.4 ± 1.2 | 0.9 ± 0.1 | 1.2 (0.5–3.7) | 0.845 |
CPB | ||||
Pump time | 120 ± 38.3 | 107.5 ± 33.1 | 114.1 (65–187) | 0.689 |
LOS (days) | 9 ± 1.9 | 17 ± 3.1 | 12.8 (5–27) | 0.026* |
Adverse events | ||||
Delirium | 2 | 3 | 5/18 | 0.598 |
Stroke/TIA | 0 | 1 | 1/18 | 1.000 |
CHF | 2 | 5 | 7/18 | 0.050* |